86 related articles for article (PubMed ID: 2151750)
1. Inhibition of adenovirus replication by the E1A antisense transcript initiated from hsp70 and VA-1 promoters.
Miroshnichenko OI; Borisenko AS; Ponomareva TI; Tikhonenko TI
Biomed Sci; 1990 Mar; 1(3):267-73. PubMed ID: 2151750
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Ad5 upstream E1 region and gene products on heterologous promoters.
Hoffmann D; Jogler C; Wildner O
J Gene Med; 2005 Oct; 7(10):1356-66. PubMed ID: 15945123
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of adenovirus 5 replication in COS-1 cells by antisense RNAs against the viral E1a region.
Miroshnichenko OI; Ponomareva TI; Tikchonenko TI
Gene; 1989 Dec; 84(1):83-9. PubMed ID: 2481607
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
[TBL] [Abstract][Full Text] [Related]
5. Trans-activation of human MYC: the second promoter is target for the stimulation by adenovirus E1a proteins.
Lipp M; Schilling R; Bernhardt G
Oncogene; 1989 May; 4(5):535-41. PubMed ID: 2471129
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus.
Jing XJ; Kalman-Maltese V; Cao X; Yang Q; Trempe JP
Virology; 2001 Dec; 291(1):140-51. PubMed ID: 11878883
[TBL] [Abstract][Full Text] [Related]
7. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences.
Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW
Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988
[TBL] [Abstract][Full Text] [Related]
8. Functional dissection of two promoters that control sense and antisense transcription of Drosophila melanogaster F elements.
Contursi C; Minchiotti G; Di Nocera PP
J Mol Biol; 1993 Dec; 234(4):988-97. PubMed ID: 8263945
[TBL] [Abstract][Full Text] [Related]
9. Transcription activation by the adenovirus E1a protein.
Lillie JW; Green MR
Nature; 1989 Mar; 338(6210):39-44. PubMed ID: 2521923
[TBL] [Abstract][Full Text] [Related]
10. Construction of modular and versatile plasmid vectors for the high-level expression of single or multiple genes in insects and insect cell lines.
Huynh CQ; Zieler H
J Mol Biol; 1999 Apr; 288(1):13-20. PubMed ID: 10329122
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production.
Aparicio O; Razquin N; Zaratiegui M; Narvaiza I; Fortes P
J Virol; 2006 Feb; 80(3):1376-84. PubMed ID: 16415015
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells.
Hamada K; Sakaue M; Alemany R; Zhang WW; Horio Y; Roth JA; Mitchell MF
Gynecol Oncol; 1996 Nov; 63(2):219-27. PubMed ID: 8910631
[TBL] [Abstract][Full Text] [Related]
13. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
14. A TATA box implicated in E1A transcriptional activation of a simple adenovirus 2 promoter.
Wu L; Rosser DS; Schmidt MC; Berk A
Nature; 1987 Apr 2-8; 326(6112):512-5. PubMed ID: 2951598
[TBL] [Abstract][Full Text] [Related]
15. Transactivation of host and viral genes by the adenovirus E1B 19K tumor antigen.
Herrmann CH; Dery CV; Mathews MB
Oncogene; 1987; 2(1):25-35. PubMed ID: 2963990
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters.
Webster KA; Muscat GE; Kedes L
Nature; 1988 Apr; 332(6164):553-7. PubMed ID: 2965790
[TBL] [Abstract][Full Text] [Related]
17. A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
Rein DT; Breidenbach M; Kirby TO; Han T; Siegal GP; Bauerschmitz GJ; Wang M; Nettelbeck DM; Tsuruta Y; Yamamoto M; Dall P; Hemminki A; Curiel DT
Clin Cancer Res; 2005 Feb; 11(3):1327-35. PubMed ID: 15709205
[TBL] [Abstract][Full Text] [Related]
18. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
19. Promoter activity of left inverted terminal repeat and downstream sequences of porcine adenovirus type 3.
Xing L; Tikoo SK
Virus Res; 2005 Apr; 109(1):51-8. PubMed ID: 15826912
[TBL] [Abstract][Full Text] [Related]
20. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
